Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avant Diagnostics Inc OREO

Healthcare Diagnostics & Research
Avant Diagnostics Inc is a medical diagnostic technology company. Business activity of the group is functioned through United States. It focuses on the commercialization of a series of proprietary microarray-based diagnostic tests that provide early detection of cancers, neurodegenerative diseases, and other chronic and severe disease states. The company's premier product is OvaDx, a non... see more

Recent & Breaking News (NDAQ:OREO)

Avant Diagnostics, Inc. Corporate Update

GlobeNewswire May 8, 2019

AVANT DIAGNOSTICS COMMENTS ON HALT OF TRADING OF COMMON STOCK

GlobeNewswire September 24, 2018

Avant Diagnostics to Present at LD Micro

PR Newswire June 1, 2018

Avant Diagnostics Announces Restructuring and Private Placement

PR Newswire Europe Non Regulatory May 30, 2018

Amarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro Test

GlobeNewswire April 6, 2018

Amarantus Appoints Barney Monte as Interim COO/CFO and Promotes Brian Harvey to Chief Regulatory Advisor

GlobeNewswire April 5, 2018

Amarantus Relocates Headquarters to WeWork at 110 Wall St. in New York City

GlobeNewswire April 2, 2018

Amarantus Completes Tender Exchange of Convertible Securities; CEO attending CNBC's Healthy Returns conference in New York City

GlobeNewswire March 28, 2018

Avant Diagnostics' Newly Appointed President & CEO Philippe Goix Delivered an Address to Shareholders

PR Newswire September 27, 2017

Avant Diagnostics Highlights Published Clinical Utility Data for Theralink® mTOR Pathway Activation Data Predicting Tamoxifen® and Other Endocrine Treatment Response in Estrogen Receptor Positive (ER+) Breast Cancer

PR Newswire July 18, 2017

Avant Diagnostics Acquires Exclusive Option to License Genetic Health Solution Technology Platform

PR Newswire July 12, 2017

Avant Diagnostics Announces Confirmatory Clinical Utility Data for Theralink® in Pancreatic Cancer

PR Newswire June 27, 2017

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink® Tumor Biomarker Platform

PR Newswire June 21, 2017

Avant Diagnostics Presented Data on TheraLink® Pancreatic Cancer Assay at the International Symposium on Pancreas Cancer 2016

GlobeNewswire June 14, 2016

SeeThruEquity Issues Company Update on Avant Diagnostics, Inc. (OTCQB: AVDX) Highlighting Completion of Recent Acquisitions

Accesswire June 8, 2016

Avant Diagnostics to Present at Upcoming Investor Conferences

GlobeNewswire May 31, 2016

Avant Diagnostics Announces Data Presentations at 2016 ASCO Annual Meeting

GlobeNewswire May 19, 2016

Avant Diagnostics Simultaneously Completes Acquisitions of Amarantus Diagnostics and Theranostics Health

GlobeNewswire May 12, 2016

Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health

PR Newswire March 7, 2016

Avant Diagnostics, Inc. To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

Accesswire February 19, 2016